A U.S. Registry of Eosinophilic Esophagitis Patients Treated With DUPIXENT® As Standard of Care
Status: Recruiting
Location: See all (54) locations...
Intervention Type: Drug
Study Type: Observational
SUMMARY
This observational research study is to better understand patients with eosinophilic esophagitis (EoE) who have recently been prescribed DUPIXENT® (dupilumab). The purpose of this research study is to look at how DUPIXENT is used in normal care of patients with EoE. Possible benefits to others include a better understanding of EoE and helping to inform research and clinical trial design leading to treatment decisions in this patient population going forward. Patient questionnaires will measure the following: * How EoE makes one feel * EoE signs and/or symptoms, eg, how difficult it is to swallow * How EoE affects quality-of-life * How EoE impacts aspects of daily life * How EoE symptoms have changed throughout the study
Eligibility
Participation Requirements
Sex: All
Minimum Age: 1
Healthy Volunteers: f
View:
• Initiating treatment with DUPIXENT® for EoE according to the USPI
• Participants aged ≥12 years and caregivers or legal guardians of participants aged \<12 years must be able to understand and complete registry-related questionnaires
Locations
United States
Arkansas
Arkansas Childrens Hospital
RECRUITING
Little Rock
Arizona
Phoenix Childrens Hospital
RECRUITING
Phoenix
Arizona Digestive Health/GI Alliance
ACTIVE_NOT_RECRUITING
Sun City
California
Scripps Clinic
ACTIVE_NOT_RECRUITING
La Jolla
University of California Los Angeles (UCLA)
ACTIVE_NOT_RECRUITING
Los Angeles
University of Southern California Keck School of Medicine
ACTIVE_NOT_RECRUITING
Los Angeles
University of California, San Francisco
RECRUITING
Oakland
University of California San Francisco (UCSF)
ACTIVE_NOT_RECRUITING
San Francisco
Colorado
Childrens Hospital Colorado
RECRUITING
Aurora
University of Colorado Anschutz Medical Campus
ACTIVE_NOT_RECRUITING
Aurora
Rocky Mountain Gastroenterology
ACTIVE_NOT_RECRUITING
Littleton
Connecticut
UConn Health - The Carole and Ray Neag Comprehensive Cancer Center
ACTIVE_NOT_RECRUITING
Farmington
Yale School of Medicine
RECRUITING
New Haven
Florida
Gastroenterology of Greater Orlando
RECRUITING
Orange City
Orlando Health
RECRUITING
Orlando
Georgia
Emory Healthcare, Emory Clinic
ACTIVE_NOT_RECRUITING
Atlanta
GI Care for Kids LLC
RECRUITING
Atlanta
Illinois
Ann & Robert H. Lurie Children's Hospital of Chicago
RECRUITING
Chicago
Northwestern University, Feinberg School of Medicine
ACTIVE_NOT_RECRUITING
Chicago
Comprehensive Gastrointestinal Health, LLC
ACTIVE_NOT_RECRUITING
Libertyville
NorthShore University Health System
RECRUITING
Skokie
Kansas
Kansas Gastroenterology LLC
ACTIVE_NOT_RECRUITING
Wichita
Kentucky
Allergy & Asthma Specialists, P.S.C.
RECRUITING
Owensboro
Massachusetts
Boston Childrens Hospital
RECRUITING
Boston
Boston Specialists
RECRUITING
Boston
Massachusetts General Hospital
RECRUITING
Boston
Minnesota
Mayo Clinic
ACTIVE_NOT_RECRUITING
Rochester
Missouri
Kansas City VA Medical Center
ACTIVE_NOT_RECRUITING
Kansas City
Washington University in Saint Louis
ACTIVE_NOT_RECRUITING
St Louis
Mississippi
GI Associates and Endoscopy Center
ACTIVE_NOT_RECRUITING
Flowood
North Carolina
University of North Carolina at Chapel Hill
RECRUITING
Chapel Hill
Duke University
ACTIVE_NOT_RECRUITING
Durham
Atrium Health / Wake Forest University School of Medicine
RECRUITING
Winston-salem
New Jersey
Allergy Partners of N.J., P.C.
ACTIVE_NOT_RECRUITING
Ocean City
New York
Steven And Alexandra Cohen Children's Medical Center Of New York
RECRUITING
Lake Success
Icahn School of Medicine at Mount Sinai
RECRUITING
New York
Weil Cornell Medicine NYP
RECRUITING
New York
Gastroenterology Group of Rochester LLP
RECRUITING
Rochester
Ohio
Great Lakes Gastroenterology Research, LLC
ACTIVE_NOT_RECRUITING
Mentor
Pennsylvania
Susquehanna Research Group
ACTIVE_NOT_RECRUITING
Camp Hill
The Children's Hospital of Philadelphia
RECRUITING
Philadelphia
University of Pennsylvania
ACTIVE_NOT_RECRUITING
Philadelphia
South Carolina
Medical University of South Carolina
RECRUITING
Charleston
Palmetto Gastroenterology Clinical Research
ACTIVE_NOT_RECRUITING
Summerville
Tennessee
Vanderbilt University Medical Center
RECRUITING
Nashville
Texas
Brooke Army Medical Center
ACTIVE_NOT_RECRUITING
Fort Sam Houston
Baylor College of Medicine
RECRUITING
Houston
GI Alliance
ACTIVE_NOT_RECRUITING
Southlake
Utah
Tanner Clinic
RECRUITING
Layton
University of Utah
WITHDRAWN
Salt Lake City
Virginia
University of Virginia
RECRUITING
Charlottesville
Washington
Seattle Children's Home Health Company
RECRUITING
Seattle
Washington Gastroenterology, GIA
ACTIVE_NOT_RECRUITING
Tacoma
Wisconsin
Medical College of Wisconsin
RECRUITING
Milwaukee
Contact Information
Primary
Clinical Trials Administrator
clinicaltrials@regeneron.com
844-734-6643
Time Frame
Start Date: 2024-11-22
Estimated Completion Date: 2030-05-22
Participants
Target number of participants: 350
Treatments
EoE Patients treated with DUPIXENT®
Related Therapeutic Areas
Sponsors
Collaborators: Sanofi
Leads: Regeneron Pharmaceuticals